Company Monitoring Page for Alkermes

latest headlines for company on cafepharma

Alkermes Shares Popped: What You Need to Know
Motley Fool
Sat, 02/5/11 - 10:50 am
Tags:
Alkermes, Risperdal Consta, Bydureon, Amylin
Alkermes Performs Better than Est.
Yahoo/Zacks.com
Fri, 02/4/11 - 11:13 am
Tags:
earnings, Alkermes, JNJ
Amylin takes smaller 4Q loss as expenses decline
Yahoo/AP
Thu, 01/27/11 - 11:30 am
Tags:
Amylin, earnings, Alkermes
Is Alkermes' Stock Cheap by the Numbers?
Motley Fool
Thu, 01/13/11 - 01:25 pm
Tags:
Alkermes
Good News for Alkermes' Pipeline
Yahoo/Zacks.com
Thu, 12/9/10 - 12:09 pm
Tags:
Alkermes, JNJ
FDA Ends October With Drug Approvals, Rejection
TheStreet.com
Mon, 11/1/10 - 08:59 am
Tags:
FDA, Biodel, Avanir, Forest Labs, Arena Pharmaceuticals, Vivus, Amylin, Questcor Pharmaceuticals, Alkermes
What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thu, 10/21/10 - 11:07 am
Tags:
Amylin, diabetes, Alkermes, Eli Lilly, Bydureon
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Bloomberg
Wed, 10/20/10 - 10:46 am
Tags:
Amylin, Eli Lilly, Alkermes, FDA, Bydureon, diabetes
One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wed, 10/20/10 - 09:32 am
Tags:
Eli Lilly, M&A, Amylin, Bydureon, diabetes, Alkermes
Alkermes' Drug Approval On Tap
Investors.com
Tue, 10/19/10 - 10:28 pm
Tags:
Alkermes, FDA, Bydureon, diabetes, Eli Lilly, Amylin, Byetta, Vivitrol, alcoholism
Update: Perfect FDA Drug Approval Pickers
TheStreet.com
Thu, 10/14/10 - 09:29 am
Tags:
FDA, Hospira, Human Genome Sciences, Alexza, Jazz Pharmaceuticals, Alkermes, Arena Pharmaceuticals, Amylin, Vivus, Avanir, Forest Labs, Biodel
Don't Get Addicted to Alkermes' Low Revenue
Motley Fool
Wed, 10/13/10 - 04:08 pm
Tags:
Alkermes, Vivitrol
Titan's Implanted Addiction-Drug Device Works Better Than Placebo in Study
Bloomberg
Wed, 10/13/10 - 08:25 am
Tags:
Titan, drug addiction, Probuphine, buprenorphine, Reckitt Benckiser, Alkermes
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Tags:
Linjeta, Biodel, Afrezza, MannKind, FDA, Benlysta, Human Genome, GSK, Bydureon, Eli Lilly, Amylin, Alkermes, Brilinta, AstraZeneca, Pradaxa, Boehringer Ingelheim, Qnexa, Vivus, Contrave, Orexigen, ipilimumab, Bristol-Myers Squibb, Merck KGaA, cladribine
Top 5 Upcoming FDA Decisions With Bullish Options Sentiment
Seeking Alpha
Sat, 09/18/10 - 11:07 am
Tags:
Ista, Alexza, Biodel, Alkermes, Vivus
FDA panel urges wider use for Alkermes drug
Reuters
Fri, 09/17/10 - 11:55 am
Tags:
FDA, advisory panels, Alkermes, addiction, Vivitrol
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
Tags:
FDA, Questcor Pharmaceuticals, Savient, Alkermes, Arena Pharmaceuticals, Roche, Novartis, Hospira, Human Genome, Alexza, Jazz Pharmaceuticals, Biodel, Amylin, Eli Lilly, Vivus, Avanir, Cadence Pharmaceuticals, Amgen, Cumberland, Orexigen, MannKind, Bristol-Myers Squibb
Amylin, Alkermes gain ground on Roche drug delay
Yahoo/AP
Fri, 06/18/10 - 11:28 am
Tags:
Roche, Amylin, Alkermes, diabetes, taspoglutide
Revenues Dip at Alkermes
Yahoo/Zacks.com
Mon, 05/17/10 - 01:34 pm
Tags:
Alkermes, earnings, Cephalon, JNJ
Alkermes leads drug stocks lower
Marketwatch
Fri, 05/14/10 - 10:03 am
Tags:
Alkermes, drug stocks

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.